跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Approved
STANDARD
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
5eb35e3d6a5e9036
Company
Unknown
Type
Standard
Approval Details
Approval Id
5eb35e3d6a5e9036
Drug Name
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Active Ingredients
Irinotecan 17.33 mg/ml eqv Irinotecan Hydrochloride
20 mg/ ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
5eb35e3d6a5e9036
Type
Standard
Back to HSA Approvals
